Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardio-vascular disease: response to Beishuizen et al.

Cicero AF, Gaddi AV, Derosa G.

Diabetes Care. 2005 May;28(5):1262-3; author reply 1263-4. No abstract available.

PMID:
15855609
[PubMed - indexed for MEDLINE]
2.

Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardiovascular disease.

Beishuizen ED, van de Ree MA, Jukema JW, Tamsma JT, van der Vijver JC, Meinders AE, Putter H, Huisman MV.

Diabetes Care. 2004 Dec;27(12):2887-92.

PMID:
15562202
[PubMed - indexed for MEDLINE]
3.

Additional lipid lowering trials using surrogate measurements of atherosclerosis by carotid intima-media thickness: more clarity or confusion?

Stein EA.

J Am Coll Cardiol. 2008 Dec 16;52(25):2206-9. doi: 10.1016/j.jacc.2008.11.002. No abstract available.

PMID:
19095140
[PubMed - indexed for MEDLINE]
Free Article
4.

No effect of statin therapy on silent myocardial ischemia in patients with type 2 diabetes without manifest cardiovascular disease.

Beishuizen ED, Jukema JW, Tamsma JT, van de Ree MA, van der Vijver JC, Putter H, Maan AC, Meinders AE, Huisman MV.

Diabetes Care. 2005 Jul;28(7):1675-9.

PMID:
15983319
[PubMed - indexed for MEDLINE]
5.

Statins and their use in preventing carotid disease.

Sillesen H.

Curr Atheroscler Rep. 2009 Jul;11(4):309-14. Review.

PMID:
19500495
[PubMed - indexed for MEDLINE]
6.

HMG-CoA reductase inhibitors suppress the development and progression of carotid artery intimal-medial thickening in hypercholesterolemic type 2 diabetic patients.

Takahashi T, Ishii N, Itai K, Goto R, Higashi K, Kobori S.

J Atheroscler Thromb. 2005;12(3):149-53.

PMID:
16020915
[PubMed - indexed for MEDLINE]
Free Article
7.

Low-density lipoprotein receptor genotype and response to pravastatin in children with familial hypercholesterolemia: substudy of an intima-media thickness trial.

Koeijvoets KC, Rodenburg J, Hutten BA, Wiegman A, Kastelein JJ, Sijbrands EJ.

Circulation. 2005 Nov 15;112(20):3168-73.

PMID:
16286607
[PubMed - indexed for MEDLINE]
Free Article
8.

Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials.

Wang JG, Staessen JA, Li Y, Van Bortel LM, Nawrot T, Fagard R, Messerli FH, Safar M.

Stroke. 2006 Jul;37(7):1933-40. Epub 2006 Jun 8.

PMID:
16763185
[PubMed - indexed for MEDLINE]
Free Article
9.
10.

The effect of statin therapy on endothelial function in type 2 diabetes without manifest cardiovascular disease.

Beishuizen ED, Tamsma JT, Jukema JW, van de Ree MA, van der Vijver JC, Meinders AE, Huisman MV.

Diabetes Care. 2005 Jul;28(7):1668-74.

PMID:
15983318
[PubMed - indexed for MEDLINE]
11.

The effect of pravastatin on intima media thickness of the carotid artery in patients with normal cholesterol.

Reid JA, Wolsley C, Lau LL, Hannon RJ, Lee B, Young IS, Soong CV.

Eur J Vasc Endovasc Surg. 2005 Nov;30(5):464-8.

PMID:
16099694
[PubMed - indexed for MEDLINE]
Free Article
12.

Effect of antihypertensive therapy on progression of carotid intima-media thickness in patients with type 2 diabetes mellitus.

Zheng L, Hodis HN, Buchanan TA, Li Y, Mack WJ.

Am J Cardiol. 2007 Apr 1;99(7):956-60. Epub 2007 Feb 15.

PMID:
17398191
[PubMed - indexed for MEDLINE]
13.

Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus.

Davidson M, Meyer PM, Haffner S, Feinstein S, D'Agostino R Sr, Kondos GT, Perez A, Chen Z, Mazzone T.

Circulation. 2008 Apr 22;117(16):2123-30. doi: 10.1161/CIRCULATIONAHA.107.746610. Epub 2008 Apr 14.

PMID:
18413496
[PubMed - indexed for MEDLINE]
Free Article
14.

Metabolic syndrome, diabetes and subclinical atherosclerosis as assessed by carotid intima-media thickness.

Kawamoto R, Tomita H, Ohtsuka N, Inoue A, Kamitani A.

J Atheroscler Thromb. 2007 Apr;14(2):78-85.

PMID:
17485892
[PubMed - indexed for MEDLINE]
Free Article
15.

Myeloperoxidase levels are not associated with carotid atherosclerosis progression in patients with familial hypercholesterolemia.

Meuwese MC, Trip MD, van Wissen S, van Miert JN, Kastelein JJ, Stroes ES.

Atherosclerosis. 2008 Apr;197(2):916-21. Epub 2007 Sep 17.

PMID:
17875305
[PubMed - indexed for MEDLINE]
16.

Long-term effects of fenofibrate on carotid intima-media thickness and augmentation index in subjects with type 2 diabetes mellitus.

Hiukka A, Westerbacka J, Leinonen ES, Watanabe H, Wiklund O, Hulten LM, Salonen JT, Tuomainen TP, Yki-Järvinen H, Keech AC, Taskinen MR.

J Am Coll Cardiol. 2008 Dec 16;52(25):2190-7. doi: 10.1016/j.jacc.2008.09.049.

PMID:
19095138
[PubMed - indexed for MEDLINE]
Free Article
17.

Diabetes and progression of coronary calcium under the influence of statin therapy.

Budoff MJ, Yu D, Nasir K, Mehrotra R, Chen L, Takasu J, Agrawal N, Liu ST, Blumenthal RS.

Am Heart J. 2005 Apr;149(4):695-700.

PMID:
15990755
[PubMed - indexed for MEDLINE]
18.

High-dose atorvastatin in peripheral arterial disease (PAD): effect on endothelial function, intima-media-thickness and local progression of PAD. An open randomized controlled pilot trial.

Spring S, Simon R, van der Loo B, Kovacevic T, Brockes C, Rousson V, Amann-Vesti B, Koppensteiner R.

Thromb Haemost. 2008 Jan;99(1):182-9. doi: 10.1160/TH07-04-0265.

PMID:
18217152
[PubMed - indexed for MEDLINE]
19.

Intense cholesterol lowering therapy with a HMG-CoA reductase inhibitor does not improve nitric oxide dependent endothelial function in type-2-diabetes--a multicenter, randomised, double-blind, three-arm placebo-controlled clinical trial.

Balletshofer BM, Goebbel S, Rittig K, Enderle M, Schmölzer I, Wascher TC, Ferenc Pap A, Westermeier T, Petzinna D, Matthaei S, Häring HU.

Exp Clin Endocrinol Diabetes. 2005 Jun;113(6):324-30.

PMID:
15977099
[PubMed - indexed for MEDLINE]
20.

Proportion of oxidized LDL relative to plasma apolipoprotein B does not change during statin therapy in patients with heterozygous familial hypercholesterolemia.

van Tits LJ, van Himbergen TM, Lemmers HL, de Graaf J, Stalenhoef AF.

Atherosclerosis. 2006 Apr;185(2):307-12. Epub 2005 Jul 11.

PMID:
16005883
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk